Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Altamira Therapeutics Ltd. (CYTOF) Weighted-Average Shares Outstanding (Diluted) data is not available for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Weighted-Average Shares Outstanding (Diluted) |
-- |
-- |
|
-- |
|
| Balance Sheet Financials | |
$0.25M |
|
$0.10M |
|
$6.88M |
|
$7.13M |
|
$2.31M |
|
-- |
|
$0.75M |
|
$3.06M |
|
$4.07M |
|
$-0.55M |
|
$4.07M |
|
5.71M |
|
| Cash Flow Statement Financials | |
$-1.38M |
|
$-0.00M |
|
$0.37M |
|
$1.00M |
|
$0.00M |
|
$-0.99M |
|
$0.26M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|